{{medical}}
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 460044105
| IUPAC_name = (''E'',''Z'')-2-(4-(2-chloro-1,2-diphenylethenyl)phenoxy)-''N'',''N''-diethylethanamine
| image = clomifene.svg
| width = 250px

<!--Clinical data-->
| image2 = Clomifene ball-and-stick.png
| tradename = Clomid及其他<ref name=Brands>{{cite web|title=International brands of clomifene -|url=https://www.drugs.com/international/clomifene.html|publisher=Drugs.com|accessdate=11 September 2016|deadurl=no|archiveurl=https://web.archive.org/web/20160920215822/https://www.drugs.com/international/clomifene.html|archivedate=20 September 2016|df=}}</ref>
| Drugs.com = {{drugs.com|monograph|clomiphene-citrate}}
| pregnancy_AU = B3
| pregnancy_US = X
| legal_AU = S4
| legal_UK = POM
| legal_US = ℞-only
| legal_status = 
| routes_of_administration = [[口服给药|口服给药]]
| class = [[選擇性雌激素受體調節物|選擇性雌激素受體調節物]]（SERM）、{{tsl|en|Progonadotropin||Progonadotropin}}

<!--Pharmacokinetic data-->
| bioavailability = 高（>90%）
| protein_bound = 
| metabolism = [[肝臟|肝臟]]（經{{tsl|en|enterohepatic circulation|腸肝循環}}）
| elimination_half-life = 5–7 天
| excretion = 主要經[[尿液|尿液]]排除，有時經[[膽汁|膽汁]]

<!--Identifiers-->
| IUPHAR_ligand = 4159
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 911-45-5
| ATC_prefix = G03
| ATC_suffix = GB02
| PubChem = 2800
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00882
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 2698
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 1HRS458QU2
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07726
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 3752
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1200667
| synonyms = Clomiphene

<!--Chemical data-->
| C=26 | H=28 | Cl=1 | N=1 | O=1
| molecular_weight = 405.966 g/mol
| SMILES = ClC(c1ccccc1)=C(c2ccc(OCCN(CC)CC)cc2)c3ccccc3
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C26H28ClNO/c1-3-28(4-2)19-20-29-24-17-15-22(16-18-24)25(21-11-7-5-8-12-21)26(27)23-13-9-6-10-14-23/h5-18H,3-4,19-20H2,1-2H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = GKIRPKYJQBWNGO-UHFFFAOYSA-N
}}
<!-- Definition and medical uses -->
'''可洛米分'''（Clomifene），為治療女性{{tsl|en|anovulation|無排卵|無排卵性}}[[不孕|不孕症]]<ref name=AHFS2016/>，包含[[多囊卵巢綜合症|多囊卵巢綜合症]]（PCOS）患者<ref name=AHFS2016/>。使用後會導致生出[[雙胞胎|雙胞胎]]的機率增加<ref name=AHFS2016/>。本品為口服藥，一天服用一次<ref name=AHFS2016>{{cite web|title=Clomiphene Citrate|url=https://www.drugs.com/monograph/clomiphene-citrate.html|publisher=The American Society of Health-System Pharmacists|accessdate=8 December 2016|deadurl=no|archiveurl=https://web.archive.org/web/20131711531000/http://www.drugs.com/monograph/clomiphene-citrate.html|archivedate=5 November 2017|df=}}</ref>。

<!-- Side effects and mechanism -->
常見副作用包含{{tsl|en|pelvic pain|骨盆痛}}及[[潮熱|潮熱]]<ref name=AHFS2016/>，其他副作用則包含視力模糊、嘔吐、睡眠障礙、[[卵巢癌|卵巢癌]]，以及[[癲癇發作|癲癇發作]]<ref name=WHO2008/><ref name=AHFS2016/>。患有[[肝臟疾病|肝臟疾病]]以及[[妊娠|妊娠]]期間不建議使用<ref name=WHO2008>{{cite book|title=WHO Model Formulary 2008|date=2009|publisher=World Health Organization|isbn=9789241547659|pages=385-386|url=http://apps.who.int/medicinedocs/documents/s16879e/s16879e.pdf|accessdate=8 December 2016|deadurl=no|archiveurl=https://web.archive.org/web/20161213060118/http://apps.who.int/medicinedocs/documents/s16879e/s16879e.pdf|archivedate=13 December 2016|df=}}</ref>。本品屬於[[選擇性雌激素受體調節物|選擇性雌激素受體調節物]]（SERM）<ref>{{cite book|last1=Ghumman|first1=Surveen|title=Principles and Practice of Controlled Ovarian Stimulation in ART|date=2015|publisher=Springer|isbn=9788132216865|page=65|url=https://books.google.ca/books?id=UxecCgAAQBAJ&pg=PA65|language=en|deadurl=no|archiveurl=https://web.archive.org/web/20161227055405/https://books.google.ca/books?id=UxecCgAAQBAJ&pg=PA65|archivedate=2016-12-27|df=}}</ref>，可促進[[下丘脑|下丘脑]]分泌[[促性腺激素释放激素|GnRH]]，刺激{{tsl|en|anterior pituitary|腦下腺前葉}}分泌{{tsl|en|gonadotropin|性腺激素}} <ref name=WHO2008/>。

<!-- History, society and culture -->
可洛米分於美國在1967年開始用於藥用<ref name=AHFS2016/>，並列名於[[世界卫生组织基本药物标准清单|世界卫生组织基本药物标准清单]]，為基礎公衛體系必備藥物之一<ref name=WHO19th>{{cite web|title=WHO Model List of Essential Medicines (19th List)|url=http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|work=World Health Organization|accessdate=8 December 2016|date=April 2015|deadurl=no|archiveurl=https://web.archive.org/web/20161213052708/http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|archivedate=13 December 2016|df=}}</ref>。本品屬於[[通用名药物|通用名药物]]<ref name=AHFS2016/>。在[[发展中国家|发展中国家]]，每次療程劑量批發價約介於 0.79 至 2.00 美金之間<ref name=ERC2014>{{cite web|title=Clomifene|url=http://erc.msh.org/dmpguide/resultsdetail.cfm?language=english&code=CLM50T&s_year=2014&year=2014&str=50%20mg&desc=Clomifene&pack=new&frm=TAB-CAP&rte=PO&class_code2=18%2E6%2E&supplement=&class_name=%2818%2E6%2E%29Ovulation%20inducers%3Cbr%3E|website=International Drug Price Indicator Guide|accessdate=8 December 2016}}{{dead link|date=2018年2月 |bot=InternetArchiveBot |fix-attempted=yes }}</ref>。美國則約 4.80 美金<ref>{{cite web|title=NADAC as of 2016-12-21 {{!}} Data.Medicaid.gov|url=https://data.medicaid.gov/Drug-Prices/NADAC-as-of-2016-12-21/6ebu-k7ew|website=Centers for Medicare and Medicaid Services|accessdate=26 December 2016|deadurl=no|archiveurl=https://web.archive.org/web/20161224234652/https://data.medicaid.gov/Drug-Prices/NADAC-as-of-2016-12-21/6ebu-k7ew|archivedate=24 December 2016|df=}}</ref>。本品在{{tsl|en|assisted reproductive technology|體外人工受精技術}}發展時期開始應用<ref name=Hist>{{cite journal|last1=Dickey|first1=RP|last2=Holtkamp|first2=DE|title=Development, pharmacology and clinical experience with clomiphene citrate.|journal=Human Reproduction Update|date=1996|volume=2|issue=6|pages=483–506|pmid=9111183|url=http://humupd.oxfordjournals.org/content/2/6/483.full.pdf|doi=10.1093/humupd/2.6.483}}</ref>。



==參見==
* {{tsl|en|Chlorotrianisene||Chlorotrianisene}}
* [[諾瓦得士|諾瓦得士]]
* {{tsl|en|Ethamoxytriphetol||Ethamoxytriphetol}}
* {{tsl|en|Broparestrol||Broparestrol}}
* {{tsl|en|Triparanol||Triparanol}}

==參考文戲==
{{Reflist|colwidth=30em}}

{{Estrogens and antiestrogens}}
{{Assisted reproductive technology}}
{{Estrogen receptor modulators}}

[[Category:24-Dehydrocholesterol_reductase_inhibitors|Category:24-Dehydrocholesterol reductase inhibitors]]
[[Category:柠檬酸盐|Category:柠檬酸盐]]
[[Category:有机氯化合物|Category:有机氯化合物]]
[[Category:芳香醚|Category:芳香醚]]
[[Category:Progonadotropins|Category:Progonadotropins]]
[[Category:選擇性雌激素受體調節物|Category:選擇性雌激素受體調節物]]
[[Category:Triphenylethylenes|Category:Triphenylethylenes]]
[[Category:世界卫生组织基本药物|Category:世界卫生组织基本药物]]
[[Category:World_Anti-Doping_Agency_prohibited_substances|Category:World Anti-Doping Agency prohibited substances]]